Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000018

Chief Medical Officer gave up 819 shares (to pay taxes)

  • Chief Medical Officer acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-16 Exercise or conversion : show line 1 in the form +2,750 4,400 D
2020-02-18 Shares withheld for taxes : show line 2 in the form −819 $52.01 $42,596 3,581 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-02-14 Grant or award : show line 3 in the form Restricted stock units +12,000 12,000 D
2020-02-14 Grant or award : show line 4 in the form Stock option (right to buy) +45,000 45,000 D
2020-02-16 Exercise or conversion : show line 5 in the form Restricted stock unit −2,750 2,750 D
Loading xslF345X03/wf-form4_158214922111232.xml…